Rachel Lee-Yin Tan, Jian Yi Soh, Elizabeth Huiwen Tham, Anne Eng Neo Goh, Zai Ru Cheng, Michael Herdman, Nan Luo
{"title":"哮喘儿童EQ-5D-Y-3L、EQ-5D-Y-5L和CHU9D心理测量特性的正面比较","authors":"Rachel Lee-Yin Tan, Jian Yi Soh, Elizabeth Huiwen Tham, Anne Eng Neo Goh, Zai Ru Cheng, Michael Herdman, Nan Luo","doi":"10.1016/j.jval.2025.08.017","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>There is limited evidence on the relative performance of generic preference-weighted health-related quality of life instruments designed for paediatric patients. This study aimed to compare the psychometric properties of EQ-5D-Y-3L (Y-3L), EQ-5D-Y-5L (Y-5L), and CHU9D in patients with asthma.</p><p><strong>Methods: </strong>Patients diagnosed with asthma, aged between 8-18 years old completed the Y-3L, Y-5L, CHU9D, and the PROMIS Asthma Impact Scale Short Form (PAIS-SF). Patients' asthma control was assessed using the Global Initiative for Asthma (GINA) classification. Patients were followed up with a single item on change in health, Y-3L, Y-5L, and CHU9D in a subsequent clinic visit. Ceiling effects of the instruments were compared. Convergent validity and known-groups validity were assessed using hypothesis testing. Responsiveness was assessed using mean change scores and Standardized Effect Size (SES).</p><p><strong>Results: </strong>A total of 164 paediatric patients (mean age:11.9; female: 31.7%) participated in the study, with 93 patients completing the follow-up survey. The ceiling effects of Y-3L, Y-5L, and CHU9D, were 54.9%, 53.7%, and 19.5%, respectively. Almost all convergent and known-group validity hypotheses tested for the three instruments, based on PAIS-SF and GINA, were met. Y-5L best discriminated between relevant known groups, while CHU9D showed better responsiveness (SES= 0.43 in children reporting improvement), compared to Y-3L (SES= 0.16), and Y-5L (SES= 0.17).</p><p><strong>Conclusion: </strong>While the EQ-5D-Y instruments demonstrated stronger construct validity, their responsiveness appeared to be limited and inferior to the CHU9D in the study sample. Further research in more clinically diverse asthma populations is needed to inform instrument selection.</p>","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":" ","pages":""},"PeriodicalIF":6.0000,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A head-to-head comparison of the psychometric properties of the EQ-5D-Y-3L, EQ-5D-Y-5L, and CHU9D in children with asthma.\",\"authors\":\"Rachel Lee-Yin Tan, Jian Yi Soh, Elizabeth Huiwen Tham, Anne Eng Neo Goh, Zai Ru Cheng, Michael Herdman, Nan Luo\",\"doi\":\"10.1016/j.jval.2025.08.017\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>There is limited evidence on the relative performance of generic preference-weighted health-related quality of life instruments designed for paediatric patients. This study aimed to compare the psychometric properties of EQ-5D-Y-3L (Y-3L), EQ-5D-Y-5L (Y-5L), and CHU9D in patients with asthma.</p><p><strong>Methods: </strong>Patients diagnosed with asthma, aged between 8-18 years old completed the Y-3L, Y-5L, CHU9D, and the PROMIS Asthma Impact Scale Short Form (PAIS-SF). Patients' asthma control was assessed using the Global Initiative for Asthma (GINA) classification. Patients were followed up with a single item on change in health, Y-3L, Y-5L, and CHU9D in a subsequent clinic visit. Ceiling effects of the instruments were compared. Convergent validity and known-groups validity were assessed using hypothesis testing. Responsiveness was assessed using mean change scores and Standardized Effect Size (SES).</p><p><strong>Results: </strong>A total of 164 paediatric patients (mean age:11.9; female: 31.7%) participated in the study, with 93 patients completing the follow-up survey. The ceiling effects of Y-3L, Y-5L, and CHU9D, were 54.9%, 53.7%, and 19.5%, respectively. Almost all convergent and known-group validity hypotheses tested for the three instruments, based on PAIS-SF and GINA, were met. Y-5L best discriminated between relevant known groups, while CHU9D showed better responsiveness (SES= 0.43 in children reporting improvement), compared to Y-3L (SES= 0.16), and Y-5L (SES= 0.17).</p><p><strong>Conclusion: </strong>While the EQ-5D-Y instruments demonstrated stronger construct validity, their responsiveness appeared to be limited and inferior to the CHU9D in the study sample. Further research in more clinically diverse asthma populations is needed to inform instrument selection.</p>\",\"PeriodicalId\":23508,\"journal\":{\"name\":\"Value in Health\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":6.0000,\"publicationDate\":\"2025-09-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Value in Health\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jval.2025.08.017\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ECONOMICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Value in Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jval.2025.08.017","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ECONOMICS","Score":null,"Total":0}
A head-to-head comparison of the psychometric properties of the EQ-5D-Y-3L, EQ-5D-Y-5L, and CHU9D in children with asthma.
Objectives: There is limited evidence on the relative performance of generic preference-weighted health-related quality of life instruments designed for paediatric patients. This study aimed to compare the psychometric properties of EQ-5D-Y-3L (Y-3L), EQ-5D-Y-5L (Y-5L), and CHU9D in patients with asthma.
Methods: Patients diagnosed with asthma, aged between 8-18 years old completed the Y-3L, Y-5L, CHU9D, and the PROMIS Asthma Impact Scale Short Form (PAIS-SF). Patients' asthma control was assessed using the Global Initiative for Asthma (GINA) classification. Patients were followed up with a single item on change in health, Y-3L, Y-5L, and CHU9D in a subsequent clinic visit. Ceiling effects of the instruments were compared. Convergent validity and known-groups validity were assessed using hypothesis testing. Responsiveness was assessed using mean change scores and Standardized Effect Size (SES).
Results: A total of 164 paediatric patients (mean age:11.9; female: 31.7%) participated in the study, with 93 patients completing the follow-up survey. The ceiling effects of Y-3L, Y-5L, and CHU9D, were 54.9%, 53.7%, and 19.5%, respectively. Almost all convergent and known-group validity hypotheses tested for the three instruments, based on PAIS-SF and GINA, were met. Y-5L best discriminated between relevant known groups, while CHU9D showed better responsiveness (SES= 0.43 in children reporting improvement), compared to Y-3L (SES= 0.16), and Y-5L (SES= 0.17).
Conclusion: While the EQ-5D-Y instruments demonstrated stronger construct validity, their responsiveness appeared to be limited and inferior to the CHU9D in the study sample. Further research in more clinically diverse asthma populations is needed to inform instrument selection.
期刊介绍:
Value in Health contains original research articles for pharmacoeconomics, health economics, and outcomes research (clinical, economic, and patient-reported outcomes/preference-based research), as well as conceptual and health policy articles that provide valuable information for health care decision-makers as well as the research community. As the official journal of ISPOR, Value in Health provides a forum for researchers, as well as health care decision-makers to translate outcomes research into health care decisions.